class name | count |
---|---|
rosids | 40 |
asterids | 10 |
Liliopsida | 3 |
Spermatophyta | 2 |
Viridiplantae | 1 |
Euphyllophyta | 1 |
eudicotyledons | 1 |
Magnoliophyta | 1 |
class name | count |
---|---|
Fabaceae
![]() |
20 |
Brassicaceae
![]() |
12 |
Solanaceae
![]() |
5 |
Streptomycetaceae
![]() |
5 |
Cucurbitaceae
![]() |
3 |
Asteraceae
![]() |
3 |
Poaceae
![]() |
2 |
Vitaceae
![]() |
2 |
Pinaceae
![]() |
2 |
Cynipidae
![]() |
2 |
Phyllanthaceae
![]() |
1 |
Dysideidae
![]() |
1 |
Euphorbiaceae
![]() |
1 |
Hydrodictyaceae
![]() |
1 |
Rutaceae
![]() |
1 |
Rhizobiaceae
![]() |
1 |
Pleosporaceae
![]() |
1 |
Pichiaceae
![]() |
1 |
Phycomycetaceae
![]() |
1 |
Lygodiaceae
![]() |
1 |
br08003 Category | # of metabolite |
---|---|
Indole alkaloids | 2 |
br08003 Category | KEGG ID | KNApSAcK ID |
---|---|---|
Indole alkaloids | C00398 | C00001434 |
Indole alkaloids | C06213 | C00026521 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00000107
![]() |
IAN
/ Indole-3-acetonitrile |
CHEMBL1812654
|
C016516
|
![]() |
||
C00000108
![]() |
IAM
/ Indole-3-acetamide / 1H-Indole-3-acetamide |
C015950
|
![]() |
|||
C00000109
![]() |
Indole-3-acetaldehyde
|
C001655
|
![]() |
|||
C00000110
![]() |
Indole-3-acetaldoxime
|
![]() |
||||
C00000114
![]() |
Tryptophol
/ Indole-3-ethanol |
CHEMBL226545
|
C005949
|
2 / 4 / 2 |
![]() |
|
C00001430
![]() |
Skatole
|
CHEMBL1329793
|
D012862
|
2 / 1 / 4 | 7 / 1 |
![]() |
C00001434
![]() |
Tryptamine
/ beta-(3-Indolyl)ethylamine |
CHEMBL6640
|
C030820
|
20 / 5 / 7 | 6 / 2 |
![]() |
C00007397
![]() |
3-Indolylmethylthiohydroximate
|
![]() |
||||
C00007418
![]() |
N-hydroxy tryptamine
|
![]() |
||||
C00007419
![]() |
1-aci-Nitro-2-indolylethane
|
![]() |
||||
C00026521
![]() |
N-Methyltryptamine
/ N10-Methyltryptamine |
CHEMBL348588
|
C035668
|
6 / 2 / 1 |
![]() |
|
C00041598
![]() |
Indole-3-methanol
|
CHEMBL155625
|
C016517
|
7 / 1 / 1 | 50 / 7 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
O75496 | Geminin | Unclassified protein | C00001430 C00001434 C00041598 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00026521 C00041598 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001434 C00041598 | 0 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001434 | 0 / 0 |
P28222 | 5-hydroxytryptamine receptor 1B | Serotonin receptor | C00001434 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001434 | 0 / 1 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001434 | 1 / 0 |
P05164 | Myeloperoxidase | Enzyme | C00001434 | 1 / 2 |
P43235 | Cathepsin K | C1A | C00001434 | 1 / 2 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00026521 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001434 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00026521 | 1 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001434 | 1 / 0 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00000114 | 4 / 2 |
P10145 | Interleukin-8 | Secreted protein | C00041598 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00000114 | 0 / 0 |
Q13315 | Serine-protein kinase ATM | Atypical serine/threonine protein kinase PIKK subfamily | C00001430 | 1 / 4 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001434 | 0 / 0 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00041598 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001434 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00041598 | 1 / 1 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001434 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001434 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00001434 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001434 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001434 | 0 / 1 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001434 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00041598 | 0 / 0 |
P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00026521 | 1 / 0 |
P28221 | 5-hydroxytryptamine receptor 1D | Serotonin receptor | C00001434 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00026521 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001434 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00026521 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00001430
C00041598
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001430
C00041598
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00001430
C00041598
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00041598
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00041598
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00041598
|
597 | BCL2A1, ACC-1, ACC-2, BCL2L5, BFL1, GRS, HBPA1 | BCL2-related protein A1 |
C00041598
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00041598
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00041598
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00041598
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00041598
|
672 | BRCA1, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53 | breast cancer 1, early onset |
C00041598
|
675 | BRCA2, BRCC2, BROVCA2, FACD, FAD, FAD1, FANCB, FANCD, FANCD1, GLM3, PNCA2 | breast cancer 2, early onset |
C00041598
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00041598
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00041598
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00041598
|
898 | CCNE1, CCNE | cyclin E1 |
C00041598
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00041598
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00041598
|
1021 | CDK6, PLSTIRE | cyclin-dependent kinase 6 (EC:2.7.11.22) |
C00041598
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00041598
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00041598
|
1030 | CDKN2B, CDK4I, INK4B, MTS2, P15, TP15, p15INK4b | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
C00041598
|
8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator |
C00041598
|
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00041598
|
1509 | CTSD, CLN10, CPSD | cathepsin D (EC:3.4.23.5) |
C00041598
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00041598
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00041598
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00041598
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00041598
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00041598
|
9518 | GDF15, GDF-15, MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB | growth differentiation factor 15 |
C00041598
|
3551 | IKBKB, IKK-beta, IKK2, IKKB, NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
C00041598
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00041598
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00041598
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00041598
|
4582 | MUC1, CA_15-3, CD227, EMA, H23AG, KL-6, MAM6, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM | mucin 1, cell surface associated |
C00041598
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00041598
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00041598
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00041598
|
9429 | ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR1, UAQTL1 | ATP-binding cassette, sub-family G (WHITE), member 2 |
C00041598
|
5328 | PLAU, ATF, BDPLT5, QPD, UPA, URK, u-PA | plasminogen activator, urokinase (EC:3.4.21.73) |
C00041598
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00041598
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00041598
|
6667 | SP1 | Sp1 transcription factor |
C00041598
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00041598
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00041598
|
7185 | TRAF1, EBI6, MGC:10353 | TNF receptor-associated factor 1 |
C00041598
|
7431 | VIM, CTRCT30 | vimentin |
C00041598
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00041598
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00001434
|
3356 | HTR2A, 5-HT2A, HTR2 | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
C00001434
|
6530 | SLC6A2, NAT1, NET, NET1, SLC6A5 | solute carrier family 6 (neurotransmitter transporter), member 2 |
C00001434
|
6531 | SLC6A3, DAT, DAT1, PKDYS | solute carrier family 6 (neurotransmitter transporter), member 3 |
C00001434
|
6532 | SLC6A4, 5-HTT, 5-HTTLPR, 5HTT, HTT, OCD1, SERT, SERT1, hSERT | solute carrier family 6 (neurotransmitter transporter), member 4 |
C00001434
|
134864 | TAAR1, RP11-295F4.9, TA1, TAR1, TRAR1 | trace amine associated receptor 1 |
C00001434
|
1553 | CYP2A13, CPAD, CYP2A, CYPIIA13 | cytochrome P450, family 2, subfamily A, polypeptide 13 (EC:1.14.14.1) |
C00001430
|
1572 | CYP2F1, C2F1, CYP2F | cytochrome P450, family 2, subfamily F, polypeptide 1 (EC:1.14.14.1) |
C00001430
|
1580 | CYP4B1, CYPIVB1, P-450HP | cytochrome P450, family 4, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00001430
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00001430
|
OMIM | preferred title | UniProt |
---|---|---|
#208900 | Ataxia-telangiectasia; at |
Q13315
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#615363 | Estrogen resistance; estrr |
P03372
|
#143100 | Huntington disease; hd |
P42858
|
#254600 | Myeloperoxidase deficiency; mpod |
P05164
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
#265800 | Pycnodysostosis |
P43235
|
KEGG | name | UniProt |
---|---|---|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00101 | Other phagocyte defects |
P05164
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P05164
(marker)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00027 | Ovarian cancer |
P38398
(related)
|
H00031 | Breast cancer |
P38398
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00273 | Pycnodysostosis |
P43235
(related)
|
H00425 | Lysosomal cysteine protease deficiencies |
P43235
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
Q13315
(related)
|
H00064 | Ataxia telangiectasia (AT) |
Q13315
(related)
|
H00094 | DNA repair defects |
Q13315
(related)
|
H00848 | Ataxia with ocular apraxia (AOA) |
Q13315
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D001943 | Breast Neoplasms |
C00041598
|
D008064 | Lipidoses |
C00041598
|
D008113 | Liver Neoplasms |
C00041598
|
D008114 | Liver Neoplasms, Experimental |
C00041598
|
D008201 | Lymphangiectasis, Intestinal |
C00041598
|
D011472 | Prostatitis |
C00041598
|
D002583 | Uterine Cervical Neoplasms |
C00041598
|
D012640 | Seizures |
C00001434
|
D014202 | Tremor |
C00001434
|
D055370 | Lung Injury |
C00001430
|